Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2010-12-2
pubmed:abstractText
Bone marrow-derived mesenchymal stem cells (BMSCs) have been demonstrated to be a promising cell sources for cardiac regeneration. Poor survival rate of transplanted BMSCs in infarcted myocardium attenuated its clinical application. It's reported that stromal-derived factor-1 (SDF-1) could protect progenitor cells including endothelial progenitor cells and embryonic stem cells from apoptosis. But little is known whether SDF-1? protein has the same protective effects on BMSCs under conditions of hypoxia and serum deprivation (hypoxia/SD). In present study, we verified that SDF-1? (0.50-2.0 ?g/ml) inhibited hypoxia/SD induced apoptosis of BMSCs through mitochondrial pathway. After administration of SDF-1?, the loss of mitochondrial membrane potential and cytochrome c released from mitochondria to cytosol were significantly inhibited, and caspase 3 activity also declined. Furthermore, the effect of SDF-1? on mitochondrial pathway was neutralized by using PI3K inhibitor (Wortmannin) and ERK1/2 inhibitor (U0126). Our observations suggested that SDF-1? inhibits hypoxia/SD induced BMSCs apoptosis through PI3K/Akt and ERK1/2 signaling pathways. These data also imply that the anti-apoptotic effect mediated by SDF-1? may enhance cell survival after cell transplantation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1573-4978
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
38
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
9-16
pubmed:meshHeading
pubmed-meshheading:20383584-Animals, pubmed-meshheading:20383584-Apoptosis, pubmed-meshheading:20383584-Caspase 3, pubmed-meshheading:20383584-Cell Hypoxia, pubmed-meshheading:20383584-Chemokine CXCL12, pubmed-meshheading:20383584-Culture Media, Serum-Free, pubmed-meshheading:20383584-Cytoprotection, pubmed-meshheading:20383584-Enzyme Activation, pubmed-meshheading:20383584-Extracellular Signal-Regulated MAP Kinases, pubmed-meshheading:20383584-Flow Cytometry, pubmed-meshheading:20383584-Humans, pubmed-meshheading:20383584-MAP Kinase Signaling System, pubmed-meshheading:20383584-Male, pubmed-meshheading:20383584-Membrane Potential, Mitochondrial, pubmed-meshheading:20383584-Mesenchymal Stem Cells, pubmed-meshheading:20383584-Mitochondria, pubmed-meshheading:20383584-Phosphatidylinositol 3-Kinases, pubmed-meshheading:20383584-Phosphorylation, pubmed-meshheading:20383584-Proto-Oncogene Proteins c-akt, pubmed-meshheading:20383584-Rats, pubmed-meshheading:20383584-Rats, Sprague-Dawley
pubmed:year
2011
pubmed:articleTitle
SDF-1? inhibits hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells through PI3K/Akt and ERK1/2 signaling pathways.
pubmed:affiliation
Research Center for Cardiac Regenerative Medicine, The Ministry of Health, Cardiovascular Institute and Fu Wai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, China.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't